Halo-Lido

About Citius Pharmaceuticals

Citius Pharmaceuticals is a publicly traded, late-stage biopharma company focused on addressing unmet needs in critical care and oncology. The company has built a diversified pipeline with three main candidates, including the recently FDA-approved LYMPHIR™. With significant founder investment and a focus on products with large market potential, Citius aims to bring novel therapies to market faster.

Therapeutic Areas